Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis

Abstract Coronavirus disease 2019 (COVID-19) global pandemic has created unique challenges to healthcare systems throughout the world. Ensuring subjects’ safety is mandatory especially in oncology, in consideration of cancer patients’ particular frailty. We examined the proportion of severe acute re...

Full description

Bibliographic Details
Main Authors: Maria Antonietta Isgrò, Maria Grazia Vitale, Egidio Celentano, Flavia Nocerino, Giuseppe Porciello, Marcello Curvietto, Domenico Mallardo, Concetta Montagnese, Luigi Russo, Nicoletta Zanaletti, Antonio Avallone, Matilde Pensabene, Michelino De Laurentiis, Sara Centonze, Sandro Pignata, Lucia Cannella, Alessandro Morabito, Francesco Caponigro, Gerardo Botti, Giuseppe Valentino Masucci, Diana Giannarelli, Ernesta Cavalcanti, Paolo Antonio Ascierto
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Journal of Translational Medicine
Subjects:
Immunotherapy
Chemotherapy
SARS-CoV-2 infections
ICIs
SARS-CoV-2 seropositivity
Online Access:https://doi.org/10.1186/s12967-021-02798-2

Internet

https://doi.org/10.1186/s12967-021-02798-2

Similar Items